SLS vs. BHC, AUP, CARA, CRON, TEV, ABT, NOT, PYR, NVO, and TLRY
Should you be buying Solaris Resources stock or one of its competitors? The main competitors of Solaris Resources include Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Cronos Group (CRON), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.
Solaris Resources vs. Its Competitors
Bausch Health Companies (TSE:BHC) and Solaris Resources (TSE:SLS) are both pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.
In the previous week, Bausch Health Companies and Bausch Health Companies both had 1 articles in the media. Solaris Resources' average media sentiment score of 0.89 beat Bausch Health Companies' score of 0.00 indicating that Solaris Resources is being referred to more favorably in the news media.
Solaris Resources has a net margin of 0.00% compared to Bausch Health Companies' net margin of -1.88%. Bausch Health Companies' return on equity of 15.87% beat Solaris Resources' return on equity.
Solaris Resources has lower revenue, but higher earnings than Bausch Health Companies. Solaris Resources is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.
79.0% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 25.1% of Solaris Resources shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Comparatively, 40.6% of Solaris Resources shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Solaris Resources has a consensus target price of C$12.50, indicating a potential upside of 77.30%. Given Solaris Resources' stronger consensus rating and higher probable upside, analysts clearly believe Solaris Resources is more favorable than Bausch Health Companies.
Bausch Health Companies has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Solaris Resources has a beta of 1.9, indicating that its share price is 90% more volatile than the S&P 500.
Summary
Solaris Resources beats Bausch Health Companies on 9 of the 14 factors compared between the two stocks.
Get Solaris Resources News Delivered to You Automatically
Sign up to receive the latest news and ratings for SLS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Solaris Resources Competitors List
Related Companies and Tools
This page (TSE:SLS) was last updated on 8/7/2025 by MarketBeat.com Staff
